Berkeley Lights to Participate in the Morgan Stanley 2020 Healthcare Conference

Rhea-AI Summary

Berkeley Lights, a leader in Digital Cell Biology, will participate in the Morgan Stanley Virtual Healthcare Conference on September 15, 2020, at 8:00 a.m. Pacific Time. The management team will engage in a fireside chat, which can be accessed via a live and archived webcast on their website. Berkeley Lights focuses on accelerating biotherapeutics development through its innovative platform, which captures critical data from single cells. Their technology aims to set industry standards in cell-based product development.

EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.

Berkeley Lights’ management is scheduled for a fireside chat on Tuesday, September 15 at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.

About Berkeley Lights

Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon and Lightning systems and Culture Station instrument are: FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Press Contact
berkeleylights@bulleitgroup.com

Investor Contact
ir@berkeleylights.com

FAQ

What is Berkeley Lights' participation in the Morgan Stanley Virtual Healthcare Conference 2020?

Berkeley Lights will participate in the Morgan Stanley Virtual Healthcare Conference on September 15, 2020, with a fireside chat scheduled at 8:00 a.m. Pacific Time.

How can I access the Berkeley Lights presentation from the Morgan Stanley Conference?

The presentation can be accessed via a live and archived webcast available in the 'Investors' section of Berkeley Lights' website.

What technologies does Berkeley Lights offer for biotherapeutics development?

Berkeley Lights offers a platform that captures deep phenotypic, functional, and genotypic information from single cells, featuring proprietary consumables and advanced automation.

What are the main goals of the Berkeley Lights Platform?

The main goal is to enable rapid development and commercialization of biotherapeutics by providing advanced solutions for functional characterization of single cells.

What is the stock symbol for Berkeley Lights?

The stock symbol for Berkeley Lights is BLI.